The effects of DPP4 inhibitors on the levels of plasma catecholamines and their metabolites in patients with type 2 diabetes

Kim, TH; Lee, K; Park, IB; Choi, CS; Ahn, TH; Lee, DH

Ahn, TH; Lee, DH (reprint author), Gachon Univ, Gil Med Ctr, Dept Internal Med, Coll Med, 21 Namdong Daero 774 Beon Gil, Incheon 21565, South Korea.

DIABETES RESEARCH AND CLINICAL PRACTICE, 2019; 156 ():

Abstract

Aims: Dipeptidyl peptidase 4 inhibitors (DPP4Is) can increase sympathetic activity. We aimed to evaluate the direct association between serum DPP4 act......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索